Skip to main content

DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq

Châtillon, France, May 12, 2026 DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a late-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq, which is being held May 19, 2026 in New York, NY. Mr. Tassé’s presentation is scheduled for Tuesday, May 19, at 9:00 am ET. A live webcast of the fireside chat can be accessed here and will also be available on the Events section of the Company’s Investors website: https://dbv-technologies.com/investor-overview/events/ A replay will also be available on DBV Technologies’ website for 90 days after the...

Continue reading

Nexxen to Host Investor Day on June 16, 2026

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), the advertising technology platform powered by unique data and media, today announced it will host an Investor Day in New York City on Tuesday, June 16, 2026. The event is expected to begin at 9:00 AM ET. Ofer Druker, Nexxen’s Chief Executive Officer, will be joined by members of the Company’s executive leadership team to present Nexxen’s strategic vision, key growth drivers, go-to-market strategy, financial outlook and product innovation, including advancements in nexAI and Nexxen TV Home Screen. The event will conclude with a live Q&A session with executive leadership. The Investor Day will be held both in-person and virtually. Due to space limitations, in-person attendance is by invitation only, and advanced registration...

Continue reading

USA Rare Earth Awarded $14.2 Million Texas Semiconductor Innovation Fund Grant to Accelerate Round Top Mountain Heavy Rare Earth Project

Texas Investment Strengthens Integrated Rare Earth Value Chain and Supports 260 New Jobs in Hudspeth County STILLWATER, Okla., May 12, 2026 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (the Company) today announced that the State of Texas has awarded the Company a $14,177,600 grant from the Texas Semiconductor Innovation Fund (TSIF) to accelerate development of its Round Top Mountain heavy rare earth project in Hudspeth County, Texas. The award supports a project expected to generate approximately 260 new jobs and to represent more than $1.4 billion in capital investment in West Texas. The Round Top Mountain deposit is one of the most significant domestic sources of heavy rare earth elements (HREEs) and select technology metals in the United States. The site contains an estimated one billion tons of material and 15 of...

Continue reading

AH Realty Trust Announces Quarterly Dividend

VIRGINIA BEACH, Va., May 12, 2026 (GLOBE NEWSWIRE) — AH Realty Trust (NYSE: AHRT), previously Armada Hoffler, announced that its Board of Directors declared the company’s regular quarterly cash dividend of $0.14 per common share. The second quarter dividend will be paid in cash on July 2, 2026, to stockholders of record on June 24, 2026. The Board of Directors also declared a cash dividend of $0.421875 per share on its 6.75% Series A Cumulative Redeemable Perpetual Preferred Stock payable on July 15, 2026, to stockholders of record on July 1, 2026. About AH Realty Trust AH Realty Trust (NYSE: AHRT), formerly known as Armada Hoffler, is a real estate investment trust (“REIT”) with over four decades of experience. The company owns and operates high-quality retail and office assets located primarily in the Mid-Atlantic and Southeastern...

Continue reading

Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company” or “KYN”) announced today the appointment of Michael J. Hennigan as an independent director of the Company, effective immediately. Following the retirements of William R. Cordes and Barry R. Pearl earlier this year, the appointment of Mr. Hennigan brings the Company’s Board to six members, five of whom are independent. Michael J. Hennigan is a highly accomplished energy executive, with several decades of leadership experience in the refining and midstream sectors. Mr. Hennigan most recently served as Executive Chairman of Marathon Petroleum Corporation (NYSE: MPC) and MPLX LP (NYSE: MPLX) until his retirement in December 2025, having previously served as Chief Executive Officer of MPC and Chairman, President and Chief Executive...

Continue reading

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026 Medtronic (NYSE: MDT) and Orchestra BioMed intend to pursue late-breaking clinical trial presentation at major cardiology conference in Q2 2027 and subsequent marketing application submission to FDA and global regulatory agencies, assuming primary endpoints are met FDA granted a second Breakthrough Device Designation (“BDD”) for AVIM Therapy specific to patients with uncontrolled hypertension despite the use of anti-hypertensive medications, and an indication for a pacemaker Virtue Trial sites progressing with site activation and patient enrollment acceleration continuing throughout 2026 Cash runway projected into Q4 2027 and through achievement of key upcoming clinical and regulatory milestonesNEW HOPE, Pa., May...

Continue reading

BROOKFIELD BANCSHARES, INC. AND FIRST NATIONAL BANK OF BROOKFIELD ANNOUNCE EXECUTION OF MERGER AGREEMENT TO ACQUIRE NSTS BANCORP, INC. AND NORTH SHORE TRUST AND SAVINGS

BROOKFIELD, Ill. and WAUKEGAN, Ill., May 12, 2026 (GLOBE NEWSWIRE) — Brookfield Bancshares, Inc. (“Brookfield”), the holding company for First National Bank of Brookfield (“FNBB”), and NSTS Bancorp, Inc. (NASDAQ: NSTS) (“NSTS”), the holding company for North Shore Trust and Savings (“North Shore”), today jointly announced the signing of a definitive merger agreement in which Brookfield will acquire NSTS and North Shore in an all-cash transaction valued at approximately $73.7 million. North Shore will continue to operate under its existing name and federal savings association charter as a subsidiary of Brookfield. North Shore’s President and Chief Executive Officer, Stephen G. Lear, will remain on North Shore’s board of directors after the acquisition. One additional individual, to be mutually agreed to by the parties, from North...

Continue reading

DoubleDown Interactive First Quarter 2026 Revenue Rises 12.7% and Earnings per Fully Diluted Common Share Increases 48.4%

SEOUL, South Korea, May 12, 2026 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital games on mobile and web-based platforms, today announced unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 vs. First Quarter 2025 Summary:Revenue rose 12.7% to $94.1 million in the first quarter of 2026 compared to $83.5 million in the first quarter of 2025.Revenue from the Company’s social casino/free-to-play games was $76.9 million in the first quarter of 2026, a 9.5% increase from the first quarter of 2025. The increase was primarily due to the contribution of revenue from WHOW Games GmbH (“WHOW Games”), which was acquired by the Company in July 2025. Direct-to-Consumer (“DTC”)1 revenue rose to $34.0 million...

Continue reading

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

Completed spin-off of First Tracks Biotherapeutics, Inc., its former biopharma operations business Now exclusively manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda Announced appointment of Chris Murphy as CFO Announced appointments of Susannah Gray, former CFO of Royalty Pharma, and Owen Hughes, current CEO of XOMA Royalty, to its Board of DirectorsSAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today reported financial results for the first quarter ended March 31, 2026, and provided a business update. “Following the completion of the spin-off of First Tracks Bio in late April, Anaptys now exclusively manages the financial collaborations for Jemperli and...

Continue reading

Public Policy Holding Company, Inc. Announces Q1 2026 Financial Results

Strong Revenue Growth Demonstrating Success of Company StrategyRevenue growth of 27.5% with organic revenue growth of 5.1% compared to Q1 2025 Completed significant talent additions, and announced an acquisition which closed in Q2 2026 PPHC added to Russell 2000® and Russell 3000® Indices as of March 23, 2026 Net Debt reduced to $1.8 million following U.S. IPOWASHINGTON, May 12, 2026 (GLOBE NEWSWIRE) — Public Policy Holding Company, Inc. (“PPHC,” “Company,” “Group”) (Nasdaq: PPHC and AIM: PPHC.L), a leading global strategic communications provider offering a comprehensive range of advisory services in the areas of Government Relations, Corporate Communications, and Public Affairs, today reported unaudited financial results for the quarter ended March 31, 2026 (“Q1 2026”). Q1 2026...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.